Comments on a Consensus Regarding Diagnostic Criteria for Neuroleptic Malignant Syndrome
J Clin Psychiatry 2012;73(2):252 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
To the Editor: A group of distinguished experts on neuroleptic malignant syndrome (NMS) has reached a consensus regarding diagnostic criteria for NMS using the Delphi technique under the coordination of Dr Ronald J. Gurrera. It is logical to assume that the use of the Delphi technique would result in a more acceptable set of criteria and probably lead to advantages for future research on NMS.
However, the implementation of this consensus may lead to some important changes and presumed advantages in the understanding of the condition that were not mentioned by the authors.
J Clin Psychiatry 2012; 73(2):252[letter]